Broad neutralization against SARS-CoV-2 variants induced by ancestral and B.1.351 AS03-Adjuvanted recombinant Plant-Derived Virus-Like particle vaccines-Reference-Cited by-同舟云学术

Broad neutralization against SARS-CoV-2 variants induced by ancestral and B.1.351 AS03-Adjuvanted recombinant Plant-Derived Virus-Like particle vaccines

Published:2022-06 Issue:30 Volume:40 Page:4017-4025
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Dubé Charlotte,Paris-Robidas Sarah,Andreani Guadalupe,Gutzeit Cindy,D'Aoust Marc-André,Ward Brian J.,Trépanier Sonia

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference84 articles.

1. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine;Baden;N Engl J Med.,2021

2. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine;Polack;N Engl J Med.,2020

3. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19;Sadoff;N Engl J Med.,2021

4. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials;Voysey;Lancet,2021

5. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies;Chen;Nat Med.,2021

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in virus-like particle-based SARS-CoV-2 vaccines;Frontiers in Cellular and Infection Microbiology;2024-06-26

2. Virus-like particles (VLPs)-based vaccines against COVID-19: Where do we stand amid the ongoing evolution of SARS-CoV-2?;Health Sciences Review;2023-12

3. Development and characterization of a plant-derived norovirus-like particle vaccine;Vaccine;2023-09

4. A perspective on SARS-CoV-2 virus-like particles vaccines;International Immunopharmacology;2023-02

5. From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era;Biomedicine & Pharmacotherapy;2023-02